Bristol Myers Squibb unveils ten-year strategy to improve access to medicines in LMICs pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
The Company enters strategic collaboration with the Access to Oncology Medicines (ATOM) Coalition to expand access to immuno-oncology therapy Opdivo in select countries PRINCETON, NJ / ACCESSWIRE / May
Performance Reflects Execution and Actions to Strengthen the Company s Long-Term Growth Profile
First Quarter Revenues were $11.9 Billion, increasing 5%
Growth Portfolio Revenues were $4.8.
Bristol Myers Beats on Revenue as Revlimid Sales Decline Slows bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.